Sustained Virologic Response in People Who Inject Drugs and/or Who Are on Opioid Agonist Therapy: Is 90% Enough?
Publication
, Journal Article
Naggie, S; Ramers, CB
Published in: Hepatol Commun
April 2019
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Hepatol Commun
DOI
EISSN
2471-254X
Publication Date
April 2019
Volume
3
Issue
4
Start / End Page
453 / 455
Location
United States
Related Subject Headings
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Naggie, S., & Ramers, C. B. (2019). Sustained Virologic Response in People Who Inject Drugs and/or Who Are on Opioid Agonist Therapy: Is 90% Enough? Hepatol Commun, 3(4), 453–455. https://doi.org/10.1002/hep4.1347
Naggie, Susanna, and Christian B. Ramers. “Sustained Virologic Response in People Who Inject Drugs and/or Who Are on Opioid Agonist Therapy: Is 90% Enough?” Hepatol Commun 3, no. 4 (April 2019): 453–55. https://doi.org/10.1002/hep4.1347.
Naggie S, Ramers CB. Sustained Virologic Response in People Who Inject Drugs and/or Who Are on Opioid Agonist Therapy: Is 90% Enough? Hepatol Commun. 2019 Apr;3(4):453–5.
Naggie, Susanna, and Christian B. Ramers. “Sustained Virologic Response in People Who Inject Drugs and/or Who Are on Opioid Agonist Therapy: Is 90% Enough?” Hepatol Commun, vol. 3, no. 4, Apr. 2019, pp. 453–55. Pubmed, doi:10.1002/hep4.1347.
Naggie S, Ramers CB. Sustained Virologic Response in People Who Inject Drugs and/or Who Are on Opioid Agonist Therapy: Is 90% Enough? Hepatol Commun. 2019 Apr;3(4):453–455.
Published In
Hepatol Commun
DOI
EISSN
2471-254X
Publication Date
April 2019
Volume
3
Issue
4
Start / End Page
453 / 455
Location
United States
Related Subject Headings
- 3202 Clinical sciences